Michael Laffan is Professor of Haemostasis and Thrombosis in the department of haematology.He trained in medicine at the University of Oxford and trained in haematology at the Hammersmith and Royal Free hospitals. His principal research interests are the structure function relationship of von Willebrand factor, in particular the role of glycosylation, and the mechanisms and regulation of thrombin generation. He is director of the Hammersmith Hospital Haemophilia centre and is responsible for postgraduate education in haematology.
et al., 2023, The effects of pathogenic variants for inherited hemostasis disorders in 140,214 UK Biobank participants., Blood
et al., 2023, Safety and Efficacy of Therapeutic Anticoagulation with Subcutaneous Unfractionated Heparin in Patients with Renal Failure., Semin Thromb Hemost
et al., 2023, Impact of thromboprophylaxis on hospital acquired thrombosis following discharge in patients admitted with COVID-19: multicentre observational study in the UK, British Journal of Haematology, Vol:202, ISSN:0007-1048, Pages:485-497
et al., 2023, Thrombosis, major bleeding, and survival in COVID-19 supported by VV- ECMO in the first vs second wave- multicentre observational study in the UK, Journal of Thrombosis and Haemostasis, ISSN:1538-7836
et al., 2023, von Willebrand factor binds to angiopoietin-2 within endothelial cells and after release from Weibel-Palade bodies, Journal of Thrombosis and Haemostasis, Vol:21, ISSN:1538-7836, Pages:1802-1812